First-Line Antibiotic for Acute Bacterial Sinusitis
Amoxicillin with or without clavulanate is the first-line antibiotic for acute bacterial sinusitis, with the choice between them depending on risk factors for antibiotic resistance.
Treatment Algorithm
For Adults Without Risk Factors for Resistance
- Standard-dose amoxicillin alone is appropriate for uncomplicated acute bacterial rhinosinusitis 1, 2
- This recommendation is based on amoxicillin's effectiveness, safety, low cost, and narrow microbiologic spectrum 1
For Adults With Risk Factors for Resistance
Amoxicillin-clavulanate (high-dose: 2g twice daily) should be prescribed when any of the following are present 1, 2:
- Antibiotic use within the past month 1
- Moderate to severe symptoms or protracted illness 1
- Age >65 years 1
- Comorbid conditions (diabetes, chronic cardiac/hepatic/renal disease, immunocompromised) 1
- Geographic regions with high rates (>10%) of penicillin-nonsusceptible Streptococcus pneumoniae 1
- Close contact with daycare facilities 1
- Recent hospitalization 1
For Children
Age ≥2 years, uncomplicated, mild-to-moderate:
- Standard-dose amoxicillin (45 mg/kg/day in 2 divided doses) 1
- In communities with high prevalence of nonsusceptible S. pneumoniae (>10%), use high-dose amoxicillin (80-90 mg/kg/day in 2 divided doses, max 2g/dose) 1
Age <2 years, attending daycare, recent antibiotics, or moderate-to-severe illness:
- High-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses) 1, 3
Penicillin-Allergic Patients
For adults with penicillin allergy:
- Doxycycline OR respiratory fluoroquinolone (levofloxacin or moxifloxacin) 1
- For non-type I hypersensitivity: clindamycin plus third-generation oral cephalosporin (cefixime or cefpodoxime) 1
For children with penicillin allergy:
- Cefdinir, cefuroxime, or cefpodoxime 1
- Second- and third-generation cephalosporins carry almost no risk of serious allergic reaction in penicillin-allergic patients 1
Antibiotics NOT Recommended as First-Line
Macrolides (azithromycin, clarithromycin) and trimethoprim-sulfamethoxazole should NOT be used due to high resistance rates 1:
- Macrolide-resistant S. pneumoniae >40% in the United States 1
- Trimethoprim-sulfamethoxazole resistance: 50% for S. pneumoniae and 27% for H. influenzae 1
Duration of Therapy
- Adults: 5-7 days of therapy is as effective as 10 days 1, 4
- Children: 10-14 days or continue for 7 days after symptom resolution 1
- Shorter courses (5 days) reduce adverse events without compromising efficacy 1
Special Considerations
For frontal, ethmoidal, or sphenoidal sinusitis:
- Consider respiratory fluoroquinolones (levofloxacin, moxifloxacin) due to higher risk of complications 1
For vomiting children or those unable to take oral medications:
- Single dose of ceftriaxone 50 mg/kg IV/IM, then switch to oral therapy after clinical improvement 1
Common Pitfalls to Avoid
- Do not prescribe antibiotics for viral rhinosinusitis lasting <10 days without worsening 1, 4
- Watchful waiting for 3 days is appropriate even for patients with persistent symptoms, as many will improve without antibiotics 2, 4
- Reassess at 72 hours if symptoms worsen or fail to improve, then consider changing or initiating antibiotics 1
- Adverse events occur in 15-40% of patients on antibiotics, most commonly GI symptoms 1